Pidotimod in recurrent respiratory infection in children with allergic rhinitis, asthma or both;Pidotimod en, infección respiratoria recurrente en el niño con rinitis alérgica, asma o ambos padecimientos

Revista Alergia Mexico

Volumn 49, Issue 2, 2002, Pages 27-32

  Vargas Correa, Jorge B ^a   Espinosa Morales, Sylvia ^a   Bolaños Ancona, Jorge C ^a   Farfán Ale, José A ^a  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

Author keywords

Asthma; Immunomodulators; Recurrent breathing infection

Indexed keywords

IMMUNOMODULATING AGENT; PIDOTIMOD;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; STATISTICAL SIGNIFICANCE;

EID: 18344413803     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Upper respiratory infections or "colds" or nasopharyngitis
2. T lymphocytes in children with recurrent respiratory infections; effect of the use of thymostimulin on the alteration of T/cells subsets
3. Glicoproteinas de Klebsiella pneumoniae como coadyuvantes en la prevención de infecciones recurrentes respiratorias en niños de 1 a 6 años de edad
4. Principios del uso juicioso en infecciones del tracto respiratorio superior
5. Immunocompetence of children with frequent respiratory infections
6. Bacterial cell wall components as immunomodulators. II. The bacterial cell wall
7. Salivary immunoglobulin A production in chronic bronchitis patients given an orally administered bacterial extract
8. In vivo study on the immunomodulating effects of OM85-BV on survival inflammatory cell recruitment and bacterial clearance in Klebsiella pneumoniae
9. Bacterial extract OM85-BV induces interleukin-12 dependent IFN-gamma production
10. Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element
11. Pidotimod in the treatment of recurrent respiratory infections in paediatric patients
12. Efficacy and safety of Pidotimod in the treatment of recurrent respiratory infections in children
13. Therapeutic efficacy and safety of Pidotimod in the treatment of urinary tract infections in children
14. Role of immunoactivation with Pidotimod in recurrent respiratory infections in childhood
15. Pidotimod in the management of recurrent pharingotonsillar infections in childhood
16. Immunoactivity of Pidotimod against episodes of recurrent tonsillitis in childhood
17. Pidotimod in the prophylaxis of recurrent acute tonsillitis in childhood in tonsils: A clinically oriented update
18. Immunoactivation by Pidotimod in children with recurrent respiratory infections
19. Prophylaxis with the novel immunomodulator Pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome
20. Tratamiento de infecciones recurrentes del tracto respiratorio
21. The in vitro effect of Pidotimod on some immune functions in cancer patients
22. Pidotimod in the management of vulvar papillomatosis: Double-blind clinical trial versus placebo
23. Valutazione dell' effetto di pidotimod sulla iperreattivita bronchiale aspecifica nell' asma allergico
24. Pidotimod. Thymodolic acid PGT/1A
25. In vitro and in vivo enhancement of neutrophil functions by PGT-1A, a new immunostimulating peptide
26. Evaluation of the effect of Pidotimod on the immune system
27. Evaluation of the kinetics of the immunomodulating activity of Pidotimod on human phagocytes
28. Evaluation of Pidotimod effects on some immune parameters
29. Guía diagnóstico terapéutica de la rinitis alérgica. Reunión de consenso. Consenso multidisciplinario en rinitis alérgica. Ixtapa Zihuatanejo, Guerrero, Sept. 1999
30. Enfermedades atópicas
31. Cellular immunity is activated and a TH-2 response is associated to early wheezing in infant after bronchiolitis
32. Viral infections and asthma
33. The contribution of viral respiratory infections to the pathogenesis of airway hyperreactivity
34. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
35. Viral and bacterial infections in the development and progression of asthma